To date, almost three hundred million people in the world have been infected with the hepatitis C virus. However, a vaccine against this dangerous disease has not yet been developed.
A terrible virus affects the cells of an organ important for human life - the liver. After that, hepatitis C creates its own copy, which extends beyond the affected cell to spread the disease.
To date, several methods have been identified for contracting viral hepatitis:
Many doctors compare hepatitis C with HIV. Cure of this deadly disease at the moment is impossible. Nevertheless, there are certain types of drugs that are designed to prevent the spread of the virus.
In such treatment, twoof the drug: "Interferon Alfa" and "Ribavirin." The first prevents the spread of the virus into healthy cells, the second is directed at counteracting its reproduction. However, this treatment regimen has a huge number of side effects and low efficacy.
Therefore, scientists continue to develop newdrugs that help fight against hepatitis C. One of the latest advances in innovative medicine is the drug "Sofosbuvir". The instructions for use contain all the necessary information about it.
The drug is available in the form of round tabletsForms, the surface of which is covered with a membrane soluble exclusively in gastric juice. This information contains the instructions attached to the preparation "Sofosbuvir". The composition of the medicine includes a unique substance having the same name as the preparation, as well as auxiliary substances.
The required dosage of the drug is 400 mg and is included in one tablet. The package contains 28 pills, which is enough for a course of treatment for a month.
Influence on the body describes thepreparation "Sofosbuvir" instructions for use. The mechanism of action, in simple terms, is that the main substance of the drug is a modern retarder of the hepatitis C enzyme. It has a complex effect on the organism affected by the virus. Clinical trials have shown that even in a severely weakened disease, a sustained positive dynamics is observed under the action of the drug. This is true for hepatitis 1-4 genotype.
However, with simultaneous infection with hepatitis C andMany doctors do not consider the use of this drug to be an HIV infection. The fact is that in this case its effectiveness is not proven. It is important to understand that, despite the detailed instructions that contain the instructions for use of the Sofosbuvir preparation, the manufacturer warns against self-medication. Intensive therapy against the chronic form of viral hepatitis C can be prescribed exclusively by an experienced physician. The course of treatment is conducted under the supervision of professionals.
Most doctors believe that the drug"Sofosbuvir" should be taken only in combination with other medicines. For this, the following schemes are traditionally used, which depend on the genotype of the disease:
In the case of side effects,associated with taking one of the drugs of combination therapy, you should stop therapy. Data on the effectiveness of treatment in persons who have not reached adulthood are absent in the world practice.
The drug "Sofosbuvir" is taken once a day in a dose prescribed by the doctor. There are rules that must be followed in this case:
A variety of additional information thatit is important to know when taking the medication, contains the instruction attached to the preparation "Sofosbuvir". Indications for the use of this drug in the complex therapy largely determine side effects.
When treating the drug should know the following:
To date, not all side effects have been identified preparation "Sofosbuvir". The instructions for use contain information that they depend on the combination of the drug with other medicines.
In the case of combining the drug with the drug "Ribavirin" there are:
With the additional introduction of the drug "Interferon Alpha" there is a risk that there will be:
In more detail, all side effects describe the instructions for use attached to the preparation "Sofosbuvir".
There are a number of analogs of the drug "Sofosbuvir". They can be divided into 2 groups. Analogues for the active substance are: "Viropak", "Grateziano", "Hepsinat", "Hopetavir". The list of drugs that have a similar therapeutic effect to Sofosbuvir is much broader. Let's name only some of them: "Algeron", "Ladipasvir", "Neovir", "Tsikloferon" and many others.
However, it is possible to single out a number of advantages of Sofosbuvira over its analogues:
Modern medicine knows not so mucheffective drugs that successfully help to fight viral hepatitis C, which has passed into the chronic stage. For adults, the German medicine "Sofosbuvir" is suitable. Instructions for use allow you to compare it with other similar medicines.
Due to the fact that this drug showsquite high efficiency, has obvious advantages in comparison with analogues, its cost is extraordinarily high. One course will cost the patient about several thousand dollars. That is why it is almost impossible to get the drug "Sofosbuvir" in pharmacies.
Today, the most perfect anda safe drug that is used to treat viral hepatitis C, is precisely this remedy. Such information is confirmed by the instruction attached to the medicament "Sofosbuvir". Analogues, according to doctors, do not allow to achieve equally significant results.
It is due to this that the drug is recognized as hugethe number of doctors around the world. They are sure that today there is simply no more effective medication that can significantly alleviate the life of seriously ill patients.
</ p>